生物支架在整形外科中的当前应用
该综述回顾美国当前临床使用的可生物降解支架,阐述其设计原理与常用产品。支架被宿主炎症细胞、成纤维细胞、血管、神经及淋巴管定植,细胞沉积细胞外基质而酶降解支架,随时间支架可被宿主组织完全替代。作者指出整形外科中支架最大用途为皮肤替代、乳房再造、腹壁重建及周围神经修复。
要点
- 支架通过宿主细胞定植与酶降解实现组织替代
- 整形外科最大用途为皮肤替代、乳房再造、腹壁重建与周围神经修复
- 软骨与骨替代及肠、膀胱、黏膜、硬脑膜衬里支撑亦属重要方向
核心结论
- 支架可被宿主组织完全替代,整形外科中最大用途为皮肤替代、乳房再造、腹壁重建及周围神经修复。
- 软骨与骨替代及肠、膀胱、黏膜、硬脑膜等衬里支撑也是重要应用方向。
- 该领域广泛研究有望为外科医生提供更多选择与改进材料以修复和再生基质结构。
研究设计与样本
- 综述美国当前临床使用的可生物降解支架文献,并阐述其设计原理与常用产品。
主要发现
- 宿主组织以炎症细胞、成纤维细胞、血管、神经和淋巴管定植支架。
- 细胞沉积细胞外基质大分子,同时酶降解支架。
- 随时间推移,支架可被宿主组织完全替代。
临床怎么用
- 整形外科医生可依据皮肤替代、乳房再造、腹壁重建及周围神经修复等主要应用场景选择可生物降解支架产品。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
BACKGROUND: Properly designed biodegradable scaffolds facilitate repair or regeneration of stromal tissues. Over the past 50 years, a variety of synthetic, semisynthetic, and decellularized scaffolds have been developed that provide surgeons with tools to reconstruct a wide array of structural defects. METHODS: The authors review the literature of biological degradable scaffolds in current clinical use in the United States and highlight their design principles and products in common use. RESULTS: Host tissues populate scaffolds with inflammatory cells, fibroblasts, blood vessels, nerves, and lymphatics. Cells lay down extracellular matrix macromolecules, whereas enzymes degrade the scaffold. Over time, the scaffold can be totally replaced by host tissues. CONCLUSIONS: The greatest use of scaffolds in plastic surgery is in skin replacement, breast reconstruction, abdominal wall reconstruction, and peripheral nerve repair. Other areas of importance are cartilage and bone replacement and support for lining replacements such as bowel, bladder, mucosa, and dura. The wide range of research being performed in this field is likely to provide surgeons with more choices and improved materials to repair and regenerate stromal structures.
引用
- Panayi AC, Orgill DP. Current Use of Biological Scaffolds in Plastic Surgery. Plast Reconstr Surg. 2019. PMID: 30286046. doi:10.1097/PRS.0000000000005102
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。